XPC-5462

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameXPC-5462
Drug Alias Namedual Nav1.6/1.2 inhibitor (Xenon Pharmaceuticals)XPC-5462
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium channel protein type II alpha subunit blockersSodium channel protein type VIII alpha subunit blockers
TargetsSodium channel protein type II alpha subunitSodium channel protein type VIII alpha subunit
Therapy Area/IndicationsEpilepsy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesXenon Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesXenon Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsEpilepsy

Other Information

ATC CodeN/A
Related LinksN/A